Oral Presentation ESA-SRB 2023 in conjunction with ENSA

A biomimetic 3D platform for high-throughput sperm selection (#76)

Farin Yazdan Parast 1 , Alecia Wong 1 , Moira K. O'Bryan 2 , Reza Nosrati 1
  1. Department of Mechanical and Aerospace Engineering, Monash University, Clayton, Victoria, Australia
  2. School of BioSciences and Bio21 Institute, University of Melbourne, Parkville, Victoria, Australia

Infertility is a prevalent global health concern affecting one in six individuals [1], with male infertility contributing to about 45% of these cases [2]. Over the past four decades, assisted reproductive technologies (ART) have emerged to combat infertility. A key step in ART is the selection of high-quality sperm, which significantly impacts the treatment’s success rate, live-birth rate, and offspring health [3]. However, current clinical sperm selection methods are largely manual, time-intensive, susceptible to operator errors and differ considerably from natural three-dimensional (3D) in vivo selection. Conventional methods have not been changed over the past 40 years, resulting in limited success rates for treatment cycles [4]. Here, we present a scalable, high throughput, and clinically relevant technology for selecting high-quality sperm via a 3D network of microchannels.

The 3D platform of the sperm selection device mimics the highly parallelized and 3D structure of the female reproductive tract and allows for high-throughput selection. The device was initially fabricated using a rapid prototyping method (3D printer) [5]. However, to facilitate clinical translation, the device design has been modified for injection moulding. Subsequently, a novel prototype composed of polystyrene was developed. During the selection time, motile sperm navigate through the microchannels to reach the outlet, while debris and non-motile cells are retained in the inlet. The selection throughput of the device is over 41%, significantly higher than previously developed microfluidic technologies. It retrieves over 1.6 million high-quality sperm in just 15 minutes which is more than sufficient for applications in IVF and IUI. Furthermore, the results indicated over 65% improvement in both DNA integrity and morphologically normal sperm.

In conclusion, we present a low-cost and rapid selection method, offering a promising possibility for conducting IUI and IVF procedures more frequently in fertility clinics.

  1. Geneva: World Health Organization, Infertility Prevalence Estimates, 1990–2021, 2023.
  2. A. Agarwal, A. Mulgund, A. Hamada, M. R. Chyatte, Reprod. Biol. Endocrinol. 2015, 13, DOI 10.1186/s12958-015-0032-1.
  3. R. Nosrati, P. J. Graham, B. Zhang, J. Riordon, A. Lagunov, T. G. Hannam, C. Escobedo, K. Jarvi, D. Sinton, Nat. Rev. Urol. 2017, 14, 707.
  4. G. M. Chambers, R. C. Paul, K. Harris, O. Fitzgerald, C. V. Boothroyd, L. Rombauts, M. G. Chapman, L. Jorm, Med. J. Aust. 2017, 207, 114.
  5. F. Yazdan Parast, M. K. O’Bryan, R. Nosrati, Adv. Mater. Technol. 2022, 7, 2101291.